Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/2/09 → 07/9/18 |
Funding
- Genentech Incorporated: $131,828.00
Phase II, Mutlicenter, Randomized, Parallel-group, Partially Blinded, Placebo and Avonex Controlled Dose Finding Study to Evaluate the Efficacy as Measured by Brain MRI Lesions, and Safety of 2 Dose Regimens of Ocrelizumab in Patients with
- Coyle, Patricia (PI)
- Kowalska, Agnieszka (CoPI)
- Krupp, Lauren (PI)
- Gerber, Oded (CoPI)
- Melville, Patricia (CoPI)
- Perkins, Candice (CoPI)
Project: Research